Detailed Analysis Into the Regulatory Landscape, Patent Landscape, Key Trends, Clinical Trails, Pricing Analysis, Market Dynamics and MoreDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Adult T-Cell ...

In a heart-warming encounter, 12-year-old Thalassemia survivor Pratham, from Bikaner, met the man who gave him a second ...

As, that fuels belly fat growth in middle age, offering a target for therapies to combat age-related obesity and disease.

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

Breeze Hunter thought she had a lingering cold. When her symptoms got worse, she was diagnosed with a rare form of cancer: ...

Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Diagnosed with thalassemia at 7 months, Pratham was cured after 7 years via a stem cell transplant from a stranger. His story highlights the urgent need for more bone marrow donors in India.

Cambridge: AstraZeneca has announced that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been ...

AstraZeneca’s Calquence plus chemoimmunotherapy approved in EU to treat adult patients with previously untreated mantle cell lymphoma: Cambridge, UK Wednesday, May 7, 2025, 09:0 ...

The resubmitted biologics license application for narsoplimab in transplant-associated thrombotic microangiopathy has been ...